Picard Medical, Inc. Cost of Revenue
Picard Medical, Inc. (PMI) reported Cost of Revenue of $2.34 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2026-08-19
- Picard Medical, Inc. cost of revenue for the quarter ending 2026-06-30 was $2.34M, a 3.54% increase year-over-year.
- Picard Medical, Inc. cost of revenue for the quarter ending 2026-03-31 was $875.00K, a 10.53% decline year-over-year.
- Picard Medical, Inc. cost of revenue for the quarter ending 2025-12-31 was $598.00K, a 14.57% decline year-over-year.
- Picard Medical, Inc. cost of revenue for the quarter ending 2025-09-30 was $1.32M, a 15.25% decline year-over-year.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.34M 10-Q · filed 2026-08-19 | $3.21M 10-Q · filed 2026-08-19 | $3.81M derived: sum of 3 quarters · filed 2026-08-19 | $5.13M derived: sum of 4 quarters · filed 2026-08-19 |
| 2026-03-31 | $875.00K 10-Q · filed 2026-05-15 | $1.47M derived: sum of 2 quarters · filed 2026-05-15 | $2.79M derived: sum of 3 quarters · filed 2026-05-15 | $5.05M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-12-31 | $598.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | $1.92M derived: sum of 2 quarters · filed 2026-05-01 | $4.17M derived: sum of 3 quarters · filed 2026-08-19 | $5.14M S-1/A · filed 2026-05-01 |
| 2025-09-30 | $1.32M 10-Q · filed 2025-11-14 | $3.58M derived: sum of 2 quarters · filed 2026-08-19 | $4.55M 10-Q · filed 2025-11-14 | $5.25M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | $2.26M 10-Q · filed 2026-08-19 | $3.23M 10-Q · filed 2026-08-19 | $3.94M derived: sum of 3 quarters · filed 2026-08-19 | $5.49M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-03-31 | $978.00K 10-Q · filed 2026-05-15 | $1.68M derived: sum of 2 quarters · filed 2026-05-15 | $3.23M derived: sum of 3 quarters · filed 2026-05-15 | $4.31M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $700.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | $2.25M derived: sum of 2 quarters · filed 2026-05-01 | $3.33M derived: sum of 3 quarters · filed 2026-05-01 | $4.50M S-1/A · filed 2026-05-01 |
| 2024-09-30 | $1.55M 10-Q · filed 2025-11-14 | $2.63M derived: sum of 2 quarters · filed 2025-11-14 | $3.80M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $1.08M 10-Q · filed 2025-09-12 | $2.25M 10-Q · filed 2025-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |